Clinical Trials
59 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
A Study of HY-0102 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
U87 CART in Treatment of Advanced Solid Tumor
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
MK-3475-E90
Wellmarker Bio
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Suzhou Immunofoco Biotechnology Co., Ltd
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Chongqing Precision Biotech Co., Ltd
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions
Cedars-Sinai Medical Center
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer
Rise Biopharmaceuticals, Inc.
Minnelide 101
Minneamrita Therapeutics LLC
A Study of YL-17231 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors
Peking University
Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor
Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.
WEE1
Impact Therapeutics, Inc.
GEN602
Genzada Pharmaceuticals USA, Inc.
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Amsterdam UMC, location VUmc
Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
Minneamrita Therapeutics LLC
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients
Betta Pharmaceuticals Co., Ltd.
Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.
Samsung Medical Center
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies
Zhongnan Hospital
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
Peking University Cancer Hospital & Institute
Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer
Benaroya Research Institute
A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd.
IORT
Loyola University
COTI2-101
Critical Outcome Technologies Inc.
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Placon Therapeutics
AFFECT
Ludwig-Maximilians - University of Munich
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer
Atlantic Health System
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Threshold Pharmaceuticals
HST
Tianjin Medical University Cancer Institute and Hospital
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Southwest Hospital, China
Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.
Wakayama Medical University
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
e-Therapeutics PLC
meso-CART
Shanghai GeneChem Co., Ltd.
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
The First Affiliated Hospital with Nanjing Medical University
Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer
US Oncology Research
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Chinese PLA General Hospital
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd.
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd.
EndoHPB
Ochsner Health System
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
National Cancer Institute (NCI)
SU006668 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)